期 |
栏目 |
标题 |
文件 |
卷 12, 编号 2 (2010) |
Articles |
Konversiya neoperabel'noy stadiiraka legkogo v operabel'nuyuu EGFR-pozitivnykh patsientovna fone lecheniya gefitinibom:dva klinicheskikh sluchaya |
|
卷 12, 编号 1 (2010) |
Articles |
Primenenie Iressy (gefitiniba)v kachestve terapii pervoy liniidlya lecheniya neoperabel'nykhadenokartsinom legkogo, soderzhashchikhmutatsiyu v gene EGFR |
|
卷 18, 编号 2 (2016) |
Articles |
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study |
(Rus)
|
卷 18, 编号 4 (2016) |
Articles |
Therapy for patients with non-small cell lung cancer in the Russian Federation: EPICLIN-Lung study |
|
卷 13, 编号 3 (2011) |
Articles |
Rol' gefitiniba v lechenii bol'nykhnemelkokletochnym rakom legkogos mutatsiey v gene retseptoraepidermal'nogo faktora rosta |
|